In Neuroblastoma, expression of PD-L1 is both constitutive and inducible by different mechanisms such as IFNG-induced signaling, with expression levels ranging from 14% to 70% in patients (14, 44, 45). The gene discussed is IFNG; the disease is neuroblastoma.